Exelixis (EXEL) Inventory Average (2013 - 2026)
Exelixis' (EXEL) quarterly Inventory Average came in at $24.1 million in Q2 2026, up 2.22% year-on-year from $23.6 million in Q2 2025, and down 1.62% quarter-over-quarter from $24.5 million in Q1 2026.
Exelixis (EXEL) Inventory Average (2013 - 2026) Analysis & Trends
Exelixis' Inventory Average history runs 14 years deep, the most recent figure standing at $24.1 million for Q2 2026.
- On a quarterly basis, Inventory Average rose 2.22% year-over-year to $24.1 million in Q2 2026; TTM through Apr 2026 was $24.1 million, a 2.22% increase from a year earlier, with the FY2026 full-year figure at $22.0 million, up 10.99% from the prior year.
- Inventory Average declined to $24.1 million in Q2 2026 per EXEL's latest filing, from $24.5 million in the prior quarter.
- Across five years, Inventory Average topped out at $31.6 million in Q1 2023 and bottomed at $19.2 million in Q1 2024.
- The 5-year median for Inventory Average is $24.5 million (2026), against an average of $25.4 million.
- Across the five-year window, Inventory Average advanced 23.62% in 2022 and slumped 39.2% in 2024, its largest moves.
- Year by year, Inventory Average stood at $30.0 million in 2022, then slipped by 29.51% to $21.2 million in 2023, then fell by 1.59% to $20.8 million in 2024, then climbed by 22.24% to $25.4 million in 2025, then slipped by 5.1% to $24.1 million in 2026.
- Per Business Quant, the three latest EXEL Inventory Average figures stand at $24.1 million (Q2 2026), $24.5 million (Q1 2026), and $25.4 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 644.91 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | 24.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 24.15 Mn |
| Jan 2, 2026 | 24.54 Mn |
| Oct 3, 2025 | 25.44 Mn |
| Jul 4, 2025 | 24.17 Mn |
| Apr 4, 2025 | 23.62 Mn |
| Jan 3, 2025 | 21.70 Mn |
| Sep 27, 2024 | 20.81 Mn |
| Jun 28, 2024 | 20.86 Mn |
| Mar 29, 2024 | 19.21 Mn |
| Dec 29, 2023 | 21.15 Mn |
| Sep 29, 2023 | 26.81 Mn |
| Jun 30, 2023 | 29.27 Mn |
| Mar 31, 2023 | 31.60 Mn |
| Dec 30, 2022 | 30.01 Mn |
| Sep 30, 2022 | 29.87 Mn |
| Jul 1, 2022 | 30.74 Mn |
| Apr 1, 2022 | 27.98 Mn |
| Dec 31, 2021 | 27.87 Mn |
| Oct 1, 2021 | 26.61 Mn |
| Jul 2, 2021 | 24.87 Mn |